Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Abingdon Health Plc

Abingdon Health is a developer and manufacturer of rapid lateral flow tests, providing contract development and manufacturing organization (CDMO) and contract research organization (CRO) services to various sectors including healthcare and environmental.

Metric
Company Name	Abingdon Health Plc
Symbol	ABDX
MSH ID	COM:ABINGDONHEALTH
Market	STOCKS
Sector	Healthcare
Industry	Medical - Diagnostics & Research
Country	GB
Stage
Employee Count	84
Website	abingdonhealth.com
LinkedIn
Founders

Metric
Market Cap	182.27K
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	7.82M
Revenue (LTM)
Revenue (NTM)
Gross Profit	4.15M
EBITDA	-1.17M
Operating Income	-2.38M
Net Income	-1.62M
EPS	-0.01
Diluted EPS	-0.01
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.58
Operating Profit Margin	-0.26
EBITDA Margin	-0.15
Net Profit Margin	-0.21
Return on Equity	-0.63
Return on Assets	-0.25
Return on Capital Employed	-0.48

ABDX

COM:ABINGDONHEALTH

Abingdon Health

Last Close

7.25

22/11 15:15

Market Cap

143.03K

Beta: -

Volume Today

131.89K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-7.93
P/B Ratio	9.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.62
EV Multiple	-5.29

Metric
Days Sales Outstanding
Days Payables Outstanding	205.85
Days Inventory Outstanding	61.98
Operating Cycle	161.16
Cash Conversion Cycle	41.38
Asset Turnover	1.21

Metric
Operating Cash Flow	-2.11M
Free Cash Flow	-2.16M
Cash Flow to Debt	-1.96
Operating Cash Flow/Sales	-0.27
Free Cash Flow Yield	0.08

Metric
Cash & Equivalents	1.83M
Accounts Receivable	-378.44K
Inventory	561.93K
Goodwill	482.93K
Debt to Capitalization	0.31
Debt to Assets	0.17
Current Ratio	2.25
Quick Ratio	1.70

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue
SG&A to Revenue	1.29